Jonathan M. Shillingford

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

Jonathan M. Shillingford, Noel Murcia, Claire H. Larson et al. · Proceedings of the National Academy of Sciences · 2006 · 790 citations · Full text

Renal Pathology, Renal Cystogenesis, Renal Inflammation +19

Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium

Keiko Miyoshi, Jonathan M. Shillingford, Gilbert H. Smith et al. · The Journal of Cell Biology · 2001 · 274 citations · Full text

Rapamycin Ameliorates PKD Resulting from Conditional Inactivation of Pkd1

Jonathan M. Shillingford, Klaus Piontek, Gregory G. Germino et al. · Journal of the American Society of Nephrology · 2010 · 257 citations · Full text

Aberrant Mtor Activation, Urology, Signal Transduction +12

Acute Myeloid Leukemia-Associated <i>Mkl1 (Mrtf-a)</i> Is a Key Regulator of Mammary Gland Function

Yi Sun, Kelli L. Boyd, Wu Xu et al. · Molecular and Cellular Biology · 2006 · 171 citations · Full text

Cell Death, Cancer Biology, Mammary Gland Development +22

Impaired differentiation and lactational failure of<i>Erbb4</i>-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5

Weiwen Long, Kay‐Uwe Wagner, K. C. Kent Lloyd et al. · Development · 2003 · 155 citations

Obligate Mediator, Breast Oncology, Genetics +16